BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,296,000 | -13.5% | 138,111 | +0.4% | 0.00% | -100.0% |
| Q2 2020 | $8,431,000 | +10.2% | 137,586 | +1.7% | 0.00% | 0.0% |
| Q1 2020 | $7,653,000 | -2.7% | 135,277 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $7,869,000 | +12.4% | 138,202 | +5.6% | 0.00% | 0.0% |
| Q3 2019 | $7,004,000 | -6.1% | 130,875 | +4.7% | 0.00% | 0.0% |
| Q2 2019 | $7,461,000 | +1.6% | 124,954 | +6.0% | 0.00% | 0.0% |
| Q1 2019 | $7,346,000 | +11.6% | 117,853 | +8.5% | 0.00% | 0.0% |
| Q4 2018 | $6,585,000 | +7.8% | 108,664 | +4.1% | 0.00% | – |
| Q3 2018 | $6,106,000 | +32.7% | 104,385 | +1.8% | 0.00% | – |
| Q2 2018 | $4,601,000 | +4.4% | 102,589 | +3.2% | 0.00% | – |
| Q1 2018 | $4,409,000 | +9.0% | 99,367 | +6.4% | 0.00% | – |
| Q4 2017 | $4,046,000 | -8.6% | 93,381 | -1.9% | 0.00% | – |
| Q3 2017 | $4,427,000 | -10.9% | 95,160 | -5.2% | 0.00% | – |
| Q2 2017 | $4,970,000 | +1.8% | 100,361 | +12.7% | 0.00% | – |
| Q1 2017 | $4,880,000 | +6.7% | 89,090 | +8.5% | 0.00% | – |
| Q4 2016 | $4,574,000 | +31.7% | 82,092 | +7.9% | 0.00% | – |
| Q3 2016 | $3,474,000 | +20.1% | 76,111 | +5.1% | 0.00% | – |
| Q2 2016 | $2,893,000 | +15.4% | 72,391 | +0.5% | 0.00% | – |
| Q1 2016 | $2,507,000 | -14.3% | 72,003 | +5.7% | 0.00% | – |
| Q4 2015 | $2,925,000 | +85.6% | 68,093 | +69.2% | 0.00% | – |
| Q1 2015 | $1,576,000 | +21.0% | 40,248 | +19.5% | 0.00% | – |
| Q4 2014 | $1,302,000 | +17.3% | 33,684 | +7.3% | 0.00% | – |
| Q3 2014 | $1,110,000 | +1.3% | 31,401 | -57.3% | 0.00% | – |
| Q4 2013 | $1,096,000 | – | 73,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |